Chow, W., Donga, P., Côté-Sergent, A., Rossi, C., Lefebvre, P., Lafeuille, M., . . . Emond, B. (2020). Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. Patient Preference & Adherence, 14, 2315. https://doi.org/10.2147/PPA.S272211
Chicago Style (17th ed.) CitationChow, Wing, Prina Donga, Aurélie Côté-Sergent, Carmine Rossi, Patrick Lefebvre, Marie-Hélène Lafeuille, Hélène Hardy, and Bruno Emond. "Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide." Patient Preference & Adherence 14 (2020): 2315. https://doi.org/10.2147/PPA.S272211.
MLA (9th ed.) CitationChow, Wing, et al. "Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide." Patient Preference & Adherence, vol. 14, 2020, p. 2315, https://doi.org/10.2147/PPA.S272211.